Falk G. Bechara

Development and validation of the International Hidradenitis Suppurativa Severity Score System ( <scp>IHS</scp> 4), a novel dynamic scoring system to assess <scp>HS</scp> severity

Christos C. Zouboulis, Thrasyvoulos Tzellos, Gregor B. E. Jemec et al. · British Journal of Dermatology · 2017 · 430 citations · Full text

Secukinumab in moderate-to-severe hidradenitis suppurativa (SUNSHINE and SUNRISE): week 16 and week 52 results of two identical, multicentre, randomised, placebo-controlled, double-blind phase 3 trials

Alexa B. Kimball, Gregor B. E. Jemec, Afsáneh Alavi et al. · The Lancet · 2023 · 270 citations

Inflammation, Double-blind Phase 3, Week 16 +5

Evaluating patients' unmet needs in hidradenitis suppurativa: Results from the Global Survey Of Impact and Healthcare Needs (VOICE) Project

Amit Garg, Erica Neuren, Denny Cha et al. · Journal of the American Academy of Dermatology · 2019 · 268 citations · Full text

Health Policy, Global Survey, Patient Safety +7

Expression of microRNAs in basal cell carcinoma

Michael Sand, Marina Skrygan, Daniel Sand et al. · British Journal of Dermatology · 2012 · 197 citations

Epiploic appendagitis – clinical characteristics of an uncommon surgical diagnosis

Michael Sand, Marcos Gelos, Falk G. Bechara et al. · BMC Surgery · 2007 · 184 citations · Full text